Table 3.

Multivariate Analyses for Various HIV Care Outcomes.

(A) Time to virologic suppression, stepwise Cox proportional hazards model, n = 521
Characteristic	aHR	95% CI	P-value
Rapid start	0.96	(0.79, 1.16)	.67
History of substance use	0.73	(0.59, 0.90)	<.01
Unstably housed	0.51	(0.35, 0.77)	<.01
(B) Medication adherence score, stepwise linear regression, n = 459
Characteristic	Estimate ± std err	95% CI	P-value
Rapid start	15.37 ± 3.06	(9.36, 21.39)	<.01
Race/Ethnicity
Hispanic/Other	ref
Non-Hispanic Black	−14.10 ± 3.38	(−20.74, −7.46)	<.01
Non-Hispanic White	−14.71 ± 4.74	(−24.06, −5.45)	<.01
Unstably housed	−14.89 ± 5.85	(−26.39, −3.39)	.01
Gender
Female	ref
Male	−5.80 ± 3.90	(−13.46, 1.85)	.14
Transgender	−22.83 ± 8.64	(−39.80, −5.85)	<.01
(C) Retention in care at 12 months, stepwise logistic regression, n = 537
Characteristic	OR	95% CI	P-value
Rapid start	1.51	(1.05, 2.19)	.03
(D) Continuous retention in care at 12 months, stepwise logistic regression, n = 536
Characteristic	aOR	95% CI	P-value
Rapid start	0.78	(0.53, 1.16)	.22
Race/ethnicity
Hispanic/other	ref
Non-Hispanic Black	0.48	(0.31, 0.77)	<.01
Non-Hispanic White	0.34	(0.19, 0.61)	<.01
Unstably housed	0.41	(0.21, 0.79)	<.01
Gender
Female	ref
Male	0.50	(0.29, 0.84)	.01
Transgender	0.57	(0.18, 1.84)	.35
(E) Sustained virologic suppression at 12 months, stepwise logistic regression, n = 524
Characteristic	aOR	95% CI	P-value
Rapid start	0.75	(0.52, 1.09)	.13
Race/ethnicity
Hispanic/other	ref
Non-Hispanic Black	0.48	(0.32, 0.73)	<.01
Non-Hispanic White	0.29	(0.17, 0.51)	<.01
Coverage
Charity/self-pay	ref
Commercial	2.52	(1.23, 5.16)	.01
Medicaid/medicare	1.70	(0.98, 2.94)	.06

Abbreviations: aHR, adjusted hazard ratio; aOR, adjusted odds ratio; CI, confidence interval.